Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01926392 · ClinicalTrials.gov registry record · Phase 4
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
A Phase 4 study of Burn, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT01926392 is a Phase 4 study of Burn that has completed, run by University of Virginia. The registered enrollment target is 8 participants, below the 52-participant average among 8 other Burn trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01926392, a Phase 4 study of Burn, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Partial thickness burns are a common, painful injury requiring a great deal of resources in their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy to silver sulfadiazine and hypothesize that the water-based therapy is superior in terms of pain control and resources required to deliver care.
Conditions Studied
Interventions
- DRUG water-soluble therapy
- DRUG silver sulfadiazine
Study Locations (1)
Virginia
- University of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01926392
The ClinicalTrials.gov registry entry for NCT01926392 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52-participant average among 8 other Burn trials with a reported enrollment target (85% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Burn appearing as the primary indexed condition, and to 2 interventions - of which water-soluble therapy is the first listed.
NCT01926392 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT01926392 about?
NCT01926392 is a clinical study titled "Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns". Partial thickness burns are a common, painful injury requiring a great deal of resources in their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy to silver sulfadiazine a...
What is the current status of trial NCT01926392?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2011-04. Estimated completion is 2011-10.
What conditions does trial NCT01926392 study?
This clinical trial studies the following conditions: Burn.
What interventions are being tested in trial NCT01926392?
The interventions under investigation include: water-soluble therapy (DRUG), silver sulfadiazine (DRUG).
Who is sponsoring clinical trial NCT01926392?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01926392 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
COMPLETED · Phase 4
-
The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
RECRUITING
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
Utilizing 3D Imaging for Burn Wound Assessment
RECRUITING
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.